Education
About Us
Working with TipRanks
Follow Us
Treatment.com International (TSE:TRUE)
:TRUE
RESEARCH TOOLSreports
Total Valuation
Treatment.com International has a market cap or net worth of $37.37M. The enterprise value is C$26.53M.
Market Cap$37.37M
Enterprise ValueC$26.53M
Share Statistics
Treatment.com International has 75,502,396 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding75,502,396
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Treatment.com International’s return on equity (ROE) is -9.53 and return on invested capital (ROIC) is -641.08%.
Return on Equity (ROE)-9.53
Return on Assets (ROA)-5.90
Return on Invested Capital (ROIC)-641.08%
Return on Capital Employed (ROCE)-7.64
Revenue Per Employee3.66K
Profits Per Employee-2.52M
Employee Count3
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio―
PS Ratio0.00
PB Ratio8.72
Price to Fair Value32.96
Price to FCF-5.51
Price to Operating Cash Flow-3.84
PEG Ratio0.21
Income Statement
In the last 12 months, Treatment.com International had revenue of 10.99K and earned -7.55M in profits. Earnings per share was -0.17.
Revenue10.99K
Gross Profit10.99K
Operating Income-6.06M
Pretax Income-7.55M
Net Income-7.55M
EBITDA-7.52M
Earnings Per Share (EPS)-0.17
Cash Flow
In the last 12 months, operating cash flow was -5.20M and capital expenditures 3.00, giving a free cash flow of -5.20M billion.
Operating Cash Flow-5.20M
Free Cash Flow-5.20M
Free Cash Flow per Share-0.07
Dividends & Yields
Treatment.com International pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.07
52-Week Price Change-34.67%
50-Day Moving Average0.42
200-Day Moving Average0.51
Relative Strength Index (RSI)60.62
Average Volume (3m)225.61K
Important Dates
Treatment.com International upcoming earnings date is Aug 27, 2025, After Close (Not Confirmed).
Last Earnings DateMay 30, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend Date―
Financial Position
Treatment.com International as a current ratio of 2.63, with Debt / Equity ratio of 6.63%
Current Ratio2.63
Quick Ratio2.63
Debt to Market Cap<0.01
Net Debt to EBITDA0.14
Interest Coverage Ratio-171.82
Taxes
In the past 12 months, Treatment.com International has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Treatment.com International EV to EBITDA ratio is -3.33, with an EV/FCF ratio of -5.64.
EV to Sales2.28K
EV to EBITDA-3.33
EV to Free Cash Flow-5.64
EV to Operating Cash Flow-5.64
Balance Sheet
Treatment.com International has $2.32M in cash and marketable securities with C$152.00K in debt, giving a net cash position of -$2.17M billion.
Cash & Marketable Securities$2.32M
Total DebtC$152.00K
Net Cash-$2.17M
Net Cash Per Share-$0.03
Tangible Book Value Per Share$0.02
Margins
Gross margin is 100.00%, with operating margin of -55111.15%, and net profit margin of -68731.51%.
Gross Margin100.00%
Operating Margin-55111.15%
Pretax Margin-68731.51%
Net Profit Margin-68731.51%
EBITDA Margin-68410.76%
EBIT Margin-68410.76%
Analyst Forecast
The average price target for Treatment.com International is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-171.18%
EPS Growth Forecast46.80%